PARP1 and cancer: Despite auranofin having several known modes of action in the cancer cell, each of them individually has an IC50 in the micromolar range (including inhibition of PARP‐1 DNA‐dependent activity, Table 1), which is far too high when compared with EC50 = 12.4 nm found in our study (Fig. 3A and Table 2).